Viewing Study NCT00064727

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-02-24 @ 10:06 AM
Study NCT ID: NCT00064727
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2003-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Congestive Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ventricular Contractile Function View
None Diastolic Dysfunction View
None PPAR gamma View
None Gene Expression Patterns View
None Insulin Sensitization View
None Glucose Intolerance View
None Intolerance View